<PAGE> 1
EXHIBIT 16
June 9, 2000
Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549
RE: PHARMAPRINT INC.
COMMISSION FILE NO. 0-21141
Dear Sir or Madam:
We were previously the principal accountant for PharmaPrint Inc. On May
12, 2000, our appointment as principal accountant was terminated. We have read
PharmaPrint Inc.'s statements, included under Item 4 of its Form 8-K/A dated
June 9, 2000, and agree with such statements.
Very truly yours,
/s/ Arthur Andersen LLP
--------------------------
Arthur Andersen LLP
